Itraconazole + Ivacaftor Interaction
Unknowninteraction on record
Description
Based on simulations of these results, a reduction of the KALYDECO dosage is recommended for patients aged 6 months and older taking concomitant strong CYP3A inhibitors, such as ketoconazole, itraconazole, posaconazole, voriconazole, telithromycin, and clarithromycin.
Source: FDA drug label - ivacaftor